Michael Byrnes
2022 - eFFECTOR Therapeutics
In 2022, Michael Byrnes earned a total compensation of $2M as Chief Financial Officer at eFFECTOR Therapeutics, a 59% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,865 |
|---|---|
| Option Awards | $1,351,611 |
| Salary | $435,735 |
| Other | $31,090 |
| Total | $1,975,301 |
Byrnes received $1.4M in option awards, accounting for 68% of the total pay in 2022.
Byrnes also received $156.9K in non-equity incentive plan, $435.7K in salary and $31.1K in other compensation.
Rankings
In 2022, Michael Byrnes' compensation ranked 1,767th out of 5,760 executives tracked by ExecPay. In other words, Byrnes earned more than 69.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,767 out of 5,760 | 69th |
Division Manufacturing | 928 out of 3,136 | 70th |
Major group Chemicals And Allied Products | 375 out of 1,422 | 74th |
Industry group Drugs | 343 out of 1,323 | 74th |
Industry Pharmaceutical Preparations | 247 out of 969 | 75th |
Source: SEC filing on May 12, 2023.
Byrnes' colleagues
We found four more compensation records of executives who worked with Michael Byrnes at eFFECTOR Therapeutics in 2022.